Capecitabine Market: Information by Application (Colon Cancer, Rectal Cancer, Breast Cancer, Others) Drug Formulation (Tablets, Capsules) and Regional Outlook — Forecast Till 2026

Jun 07, 2019   Global Statistics Representing Capecitabine Market Scenario Capecitabine is a chemotherapeutic agent used in the treatment of metastatic breast and colorectal cancers. Cancer is the second leading cause of death worldwide–around 9.6 million deaths every year are caused by cancer, WHO. In addition, more than 70% of deaths occur in low and middle-income countries. Thereon, with the increasing prevalence of cancer incidences worldwide, the overall demand for chemotherapeutic agents has incre...
Request Free Sample Report

Table Of Content

TABLE OF CONTENTS

1          Introduction

1.1       Market Definition

1.2       Market Scope

2          Research Methodology

2.1       Primary Research

2.2       Research Methodology

2.3       Assumptions & Exclusions

2.4       Secondary Data Sources

3          Market Overview

3.1       Report Segmentation & Scope

3.2       Value Chain Analysis: Capecitabine Market

3.3       Key Market Trends

3.3.1    Drivers

3.3.2    Restraints

3.3.3    Opportunities

3.4       Porter’s Five Forces Analysis

3.4.1    Bargaining Power of Suppliers

3.4.2    Bargaining Power of Buyers

3.4.3    Threat of Substitution

3.4.4    Threat of New Entrants

3.4.5    Competitive Rivalry

3.5       Market Share Analysis

4          Application Overview

4.1       Introduction

4.1.1    Market Size & Forecast

4.2       Colon Cancer

4.3       Rectal Cancer

4.4       Breast Cancer

4.5       Gastric Cancer

4.6       Others

5          Drug Formulation Overview

5.1       Introduction

5.1.1    Market Size & Forecast

5.2       Tablets

5.3       Capsules

6          Regional Overview

6.1       Introduction

6.1.1    Market Size & Forecast

6.2       America

6.2.1    North America

6.2.1.1 U.S.

6.2.1.1.1          By Application

6.2.1.1.2          By Drug Formulation

6.2.1.2 Canada

6.2.1.2.1          By Application

6.2.1.2.2          By Drug Formulation

6.2.1.3 Mexico

6.2.1.3.1          By Application

6.2.1.3.2          By Drug Formulation

6.2.2    Latin America

6.2.2.1             By Application

6.2.2.2             By Drug Formulation

6.3       Europe

6.3.1    Market Size & Forecast

6.3.2    Germany

6.3.2.1             By Application

6.3.2.2             By Drug Formulation

6.3.3    France

6.3.3.1             By Application

6.3.3.2             By Drug Formulation

6.3. 4   U.K

6.3.4.1             By Application

6.3.4.2             By Drug Formulation

6.3.5    Italy

6.3.5.1             By Application

6.3.5.2             By Drug Formulation

6.3.6    Spain

6.3.6.1             By Application

6.3.6.2             By Drug Formulation

6.3.7    Rest of Europe

6.3.7.1             By Application

6.3.7.2             By Drug Formulation

6.4       Asia Pacific

6.4.1    Market Size & Forecast

6.4.2    Japan

6.4.2.1             By Application

6.4.2.2             By Drug Formulation

6.4.3    China

6.4.3.1             By Application

6.4.3.2             By Drug Formulation

6.4.4    Australia

6.4.4.1             By Application

6.4.4.2             By Drug Formulation

6.4.5    India

6.4.5.1             By Application

6.4.5.2             By Drug Formulation

6.4.6    South Korea

6.4.6.1             By Application

6.4.6.2             By Drug Formulation

6.4.7    Rest of Asia-Pacific

6.4.7.1             By Application

6.4.7.2             By Drug Formulation

6.5       Middle East & Africa

6.5.1    Market Size & Forecast

6.5.2    Saudi Arabia

6.5.2.1             By Application

6.5.2.2             By Drug Formulation

6.5.3    South Africa

6.5.3.1             By Application

6.5.3.2             By Drug Formulation

6.5.4    Kuwait

6.5.4.1             By Application

6.5.4.2             By Drug Formulation

6.5.5    Rest of Middle East & Africa

6.5.5.1             By Application

6.5.5.2             By Drug Formulation

7          Company Profile

7.1       Fresenius SE & Co. KGaA

7.1.1    Company Overview

7.1.2    Financial Performance

7.1.3    Recent Developments

7.1.4    Product Portfolio

7.2       Genentech, Inc.

7.2.1    Company Overview

7.2.2    Financial Performance

7.2.3    Recent Developments

7.2.4    Product Portfolio

7.3       Dr Reddy Laboratories Ltd.

7.3.1    Company Overview

7.3.2    Financial Performance

7.3.3    Recent Developments

7.3.4    Product Portfolio

7.4       Cipla Inc.

7.4.1    Company Overview

7.4.2    Financial Performance

7.4.3    Recent Developments

7.4.4    Product Portfolio

7.5       Accord Healthcare Ltd.

7.5.1    Company Overview

7.5.2    Financial Performance

7.5.3    Recent Developments

7.5.4    Product Portfolio

7.6       F. Hoffmann-La Roche

7.6.1    Company Overview

7.6.2    Financial Performance

7.6.3    Recent Developments

7.6.4    Product Portfolio

7.7       Teva Pharma B.V.

7.7.1    Company Overview

7.7.2    Financial Performance

7.7.3    Recent Developments

7.7.4    Product Portfolio

7.8       Sandoz

7.8.1    Company Overview

7.8.2    Financial Performance

7.8.3    Recent Developments

7.8.4    Product Portfolio

7.9       Zentiva N.V.

7.9.1    Company Overview

7.9.2    Financial Performance

7.9.3    Recent Developments

7.9.4    Product Portfolio

7.10     Ranbaxy Laboratories Ltd.

7.10.1  Company Overview

7.10.2  Financial Performance

7.10.3  Recent Developments

7.10.4  Product Portfolio